OSE Pharma plans IPO on Euronext Paris

Country

France

France-based OSE Pharma SA, which is developing immunotherapies for cancer, is planning an initial public offering of its shares on the Euronext stock exchange in Paris. Proceeds from the offering would be used to finance a Phase 3 study of its lead product for non-small cell lung cancer.